Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCI

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:CSCI - Post by User

Comment by Apostataon Aug 28, 2024 10:43am
117 Views
Post# 36199310

RE:Game over

RE:Game over
Stinzo wrote: Imagine merging with a company that is just draining cash and who's pipeline is now worthless ... What a deal ...

I now have lost considerable amount of money because of my 8 years investment in ceapro ... what a nightmare journey... All because of one man with no dignity or respect for shareholders, I am unfortunately too distant and with too little knowledge to know how these types of companies are managed. Not sure how Canada/USA can consider this CEO ethical and his actions legal ... 

In a common sense world, the CEO or board of directors would do a share buy back with all the cash they have in the bank or buy themselves shares. But seems like this company can just decide to drain shareholders cash instead while still being employed with zero accountability ...


This is the sad part. Ceapro had promise, and, like Stinzo, I (among others here) invested in that promise, thinking that it was in the steady hands of a seasoned business leader. Fast forward years later and this has turned into a clown show.

Gilles Gagnon wants it both ways. He wants to have a publicly traded company but also manage it unilaterally (ie without regard for shareholders) like a private company. It's been a series of embarrassing prat falls and failures, culminating in the Ceapro/AEZS shell game/merger. And now they've $hit the bed once more with their macimorelin dud (a holdover from AEZS -- yes, we get to witness all the terrible ideas AEZS had cooking, which no one invested in).

Please step down, Gilles. We need a responsible (and responsive) CEO.
<< Previous
Bullboard Posts
Next >>